PixCell Medical – Portable Point of Care (poct) blood test diagnostics

See Now, Act Now

We help health practitioners and patients get
rapid blood test diagnostics and information
for critical decisions when it matters most.
Designing Revolutionary Rapid Blood Testing Diagnostics,
For Revolutionary Rapid
Front-Lines Medical Decisions.
Simplify real-time blood
testing, for everyone,
everywhere.

The Mission

To transform early detection of cancer, heart failure and infection

To transform early detection of cancer, heart failure and infection
The Product

HemoScreen: An on demand miniature lab

HemoScreen: An on demand miniature lab
The Technology

Disruptive microfluidic and AI based technology

Disruptive microfluidic and AI based technology

The Mission

PixCell is transforming blood testing

The HemoScreen platform can perform highly complex blood tests, currently confined to high-end labs, in a simple, portable poc instrument. Making such blood tests extremely accessible, will enable early detection of the most critical health issues and thus save lives.

The Product

HemoScreen™

A portable Point of Care blood test analyzer that makes the most common testing simple and accessible anywhere.

The test is exceptionally effortless to perform and takes only 5 minutes.

It includes 3 simple steps:

1 Draw Blood Sample

2 Insert Sample into Cartridge

3 Insert Cartridge into Reader

Smart Disposable
Cartridge

Ensures sample preparation is automatic and includes all necessary reagents.

The Technology

PixCell’s technology harnesses microfluidics, Lab-On-A-Cartridge and AI to solve a decades old problem. The method employs a new physical phenomenon: Viscoelastic Focusing that causes cells to focus as they flow facilitating their optical analysis.

In the Pipeline: Machine Vision, AI and Microfluidics unravel new diagnostic capabilities

Applying Machine Vision, AI and Lab-On-A-Cartridge to in-vitro diagnostics make the HemoScreen™ a versatile platform for poct, that makes heart failure, cancer and infection-related assays easily accessible.

Awards & Recognition

HemoScreen Receives FDA 510(k) Clearance making it the first Cartridge Base True Point of Care Hematology Analyzer that brings critical tests to the doctor’s office

Read More
PixCell had been awarded $3M by the European Innovation Commission to expedite the HemoScreen commercialization and disrupt the POC Hematology diagnostics market

Read More
The HemoScreen receives CE mark for use in the European Union.

Read More
PixCell’s HemoScreen has been selected for display at the Israel Innovation Expo first cohort at the Peres Center for Innovation and Peace

Read More